Conjugation of Cetuximab - Puromycin and Its Target-Specific Effect on Triple Negative Breast Cancer Cell Lines

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Conjugation of Cetuximab - Puromycin and Its Target-Specific Effect on Triple Negative Breast Cancer Cell Lines'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences